שווי פעילות לרווח לפני ריבית, מסים ופחת Grifols (GRFS)

Grifols, S.A. (GRFS) dominates the plasma niche due to inelastic demand and a global collection network. The business is currently undergoing a stabilization phase following an operational downturn, restoring its margins. The business valuation via EV/EBITDA visualizes this trend, where the indicator reaches 7.36. New management is focused on optimizing the structure and reducing debt to regain investor confidence.

The global network of plasma collection centers and the diagnostic business of Grifols, S.A. (GRFS) stabilize margins, which is critical when analyzing a capital-intensive model. The current value of 7.36 reflects the ratio of total business value to operating profit before depreciation, allowing the EV/EBITDA dynamics to assess the company's debt sustainability and margin of safety amid high interest rates.